| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | BTB | 3.41e-05 | 180 | 128 | 8 | SM00225 | |
| Domain | BTB/POZ_dom | 4.14e-05 | 185 | 128 | 8 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 4.82e-05 | 189 | 128 | 8 | IPR011333 | |
| Domain | Neurexin-like | 1.08e-04 | 14 | 128 | 3 | IPR003585 | |
| Domain | 4.1m | 1.08e-04 | 14 | 128 | 3 | SM00294 | |
| Domain | K_chnl_volt-dep_Kv6 | 1.39e-04 | 3 | 128 | 2 | IPR003969 | |
| Domain | SYNDECAN | 2.77e-04 | 4 | 128 | 2 | PS00964 | |
| Domain | Syndecan | 2.77e-04 | 4 | 128 | 2 | IPR001050 | |
| Domain | Syndecan_CS | 2.77e-04 | 4 | 128 | 2 | IPR030479 | |
| Pubmed | DCAF1 ATXN7L2 ATN1 VPS72 L1TD1 HIC2 ZC3H18 SRCAP RMDN3 ZBTB7A SUGP2 UBR5 RPTOR FIZ1 EPC1 DHPS ZBTB10 TAF1 DDX41 PHF10 CEP170B PRRC2B BAHCC1 SORL1 | 6.61e-12 | 1116 | 133 | 24 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 ATN1 CAMSAP3 NUP98 FAM91A1 ZC3H18 CHD7 WRAP53 PGRMC1 HNRNPC ESF1 STK10 ZBTB7A SUGP2 RPTOR ZNF516 SAFB2 DDX41 PHF10 | 1.44e-10 | 774 | 133 | 19 | 15302935 |
| Pubmed | DCAF1 ZHX3 FKBP15 SNPH PPM1E FAM91A1 SUGP2 UBR5 SPHKAP DAAM2 MAPKBP1 ARHGAP21 CEP170B PRRC2B | 6.27e-10 | 407 | 133 | 14 | 12693553 | |
| Pubmed | CCDC22 CDC42BPA PPM1E CAMSAP3 NUP98 FAM91A1 DTNBP1 ESF1 ABRAXAS2 MTMR7 ARVCF CEBPZ PTPRZ1 DHPS STYXL1 PPP1R9B HERC2 CDC25B SCIN PRRC2B | 3.55e-09 | 1049 | 133 | 20 | 27880917 | |
| Pubmed | MAPK8IP1 FKBP15 CTTNBP2 APC2 CAMSAP3 CHD7 ARVCF UBR5 RPTOR SPHKAP ZNF516 SAFB2 PLCB1 PRKAR2B PPP1R9B HERC2 ARHGAP21 CEP170B PRRC2B | 5.24e-09 | 963 | 133 | 19 | 28671696 | |
| Pubmed | 9.19e-09 | 210 | 133 | 10 | 16565220 | ||
| Pubmed | ZHX3 ATXN7L2 CDC42BPA ATN1 VPS72 NUP98 HIC2 ZC3H18 CHD7 SRCAP PGRMC1 RFXAP ZBTB7A SUGP2 ZNF516 EPC1 ZBTB10 TAF1 HERC2 PHF10 PRRC2B SORL1 | 2.58e-08 | 1429 | 133 | 22 | 35140242 | |
| Pubmed | ZHX3 FAT4 ATXN7L2 ATN1 NOC2L MATN2 TTC19 BRF1 SUGP2 TAF1 MAPKBP1 HCLS1 PRRC2B TGS1 | 9.76e-08 | 608 | 133 | 14 | 16713569 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATXN7L2 VPS72 NOC2L NUP98 ZC3H18 CHD7 E4F1 SRCAP TTF1 RFXAP HNRNPC ZBTB7A CEBPZ FIZ1 EPC1 ANKRD11 SAFB2 UHRF1 NOL7 DDX41 | 1.13e-07 | 1294 | 133 | 20 | 30804502 |
| Pubmed | 2.30e-07 | 67 | 133 | 6 | 29254152 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | B4GALNT4 CDC42BPA WRAP53 SRCAP RYR1 STK10 SUGP2 ARVCF KCNG1 RPTOR ZNF516 ANKRD11 HERC2 MAPKBP1 ARHGAP21 CEP170B PRRC2B BAHCC1 | 2.41e-07 | 1105 | 133 | 18 | 35748872 |
| Pubmed | SP3 CDC42BPA VPS72 NOC2L MKRN1 CAMSAP3 FAM91A1 CHD7 E4F1 WRAP53 TTF1 ESF1 RMDN3 ZBTB7A IFRD1 CEBPZ ANKRD11 NOL7 HERC2 SDC4 CEP170B | 2.62e-07 | 1497 | 133 | 21 | 31527615 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP3 ATN1 RANBP3 TMEM151B APC2 NUP98 CHD7 DTNBP1 APOBR HNRNPC STK10 | 8.88e-07 | 430 | 133 | 11 | 35044719 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 CCDC22 NOC2L CHD7 SRCAP NCAPH HNRNPC ESF1 SUGP2 ARVCF UBR5 CEBPZ RPTOR SAFB2 ZBTB10 HERC2 DDX41 METAP2 SDC4 | 1.02e-06 | 1353 | 133 | 19 | 29467282 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.09e-06 | 351 | 133 | 10 | 38297188 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | FKBP15 CCDC22 NUP98 ZC3H18 RETREG3 CEP68 DTWD2 SUGP2 UBR5 CEBPZ PRKAR2B HERC2 PRRC2B TGS1 | 1.28e-06 | 754 | 133 | 14 | 33060197 |
| Pubmed | ZHX3 SP3 MKRN1 ZBTB8B POU3F1 SRCAP ZBTB7A ZBTB46 ZNF516 FIZ1 UHRF1 PHF10 ZNF367 ZNF697 | 2.85e-06 | 808 | 133 | 14 | 20412781 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | VPS72 ZC3H18 CHD7 SRCAP BRF1 UBR5 RPTOR ZNF516 SCIN CEP170B PRRC2B SORL1 | 2.92e-06 | 588 | 133 | 12 | 38580884 |
| Pubmed | Probing cellular protein complexes using single-molecule pull-down. | 3.02e-06 | 8 | 133 | 3 | 21614075 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 VPS72 NUP98 ZC3H18 CHD7 HNRNPC ESF1 IFRD1 SUGP2 CEBPZ ANKRD11 SAFB2 NOL7 TAF1 DDX41 | 4.02e-06 | 954 | 133 | 15 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 ZC3H18 CHD7 SRCAP RFXAP ZBTB10 UHRF1 NOL7 TAF1 HERC2 DDX41 METAP2 | 4.11e-06 | 608 | 133 | 12 | 36089195 |
| Pubmed | 4.46e-06 | 63 | 133 | 5 | 34351428 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NOC2L NUP98 THUMPD1 HIC2 E4F1 NCAPH TTF1 RMDN3 IFRD1 SUGP2 UBR5 EPC1 ZBTB10 SORL1 | 5.58e-06 | 857 | 133 | 14 | 25609649 |
| Pubmed | 5.93e-06 | 251 | 133 | 8 | 28077445 | ||
| Pubmed | CADM3 MAPK8IP1 FKBP15 CDC42BPA OGFR CAMSAP3 FAM91A1 RPS6KC1 SUGP2 AJM1 RPTOR SPHKAP PLCB1 PRKAR2B PPP1R9B CEP170B | 7.80e-06 | 1139 | 133 | 16 | 36417873 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | VPS72 NOC2L NUP98 SRCAP ESF1 RPS6KC1 UBR5 CEBPZ ZBTB10 HERC2 | 8.02e-06 | 440 | 133 | 10 | 34244565 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | CDC42BPA ATN1 ERN1 NOC2L CHD7 RYR1 SUGP2 EPC1 STYXL1 TAF1 HERC2 | 9.62e-06 | 552 | 133 | 11 | 10737800 |
| Pubmed | 1.12e-05 | 274 | 133 | 8 | 34244482 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 15371336 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29516630 | ||
| Pubmed | Dysbindin-associated proteome in the p2 synaptosome fraction of mouse brain. | 1.45e-05 | 2 | 133 | 2 | 25198678 | |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 1.93e-05 | 14 | 133 | 3 | 27626314 | |
| Pubmed | CDC42BPA FAM91A1 CHD7 WRAP53 TTF1 PGRMC1 HNRNPC RRAGD SUGP2 CEBPZ UHRF1 NOL7 HERC2 DDX41 PHF10 METAP2 PRRC2B | 2.00e-05 | 1371 | 133 | 17 | 36244648 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.22e-05 | 394 | 133 | 9 | 27248496 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CTTNBP2 VPS72 CAMSAP3 CHD7 WRAP53 NCAPH RETREG3 ABRAXAS2 BNIP2 ARVCF DDHD1 EPC1 DHPS DAAM2 ZNF367 PRRC2B | 2.26e-05 | 1242 | 133 | 16 | 30973865 |
| Pubmed | CTTNBP2 CDC42BPA MKRN1 DTNBP1 RYR1 TTC19 BNIP2 TAF1 ARHGAP21 TGS1 | 2.28e-05 | 497 | 133 | 10 | 23414517 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 FKBP15 NUP98 PGRMC1 ABRAXAS2 RMDN3 MTMR7 UBR5 DHPS STYXL1 CDC25B PRRC2B HSP90AA4P SORL1 | 2.33e-05 | 974 | 133 | 14 | 28675297 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.36e-05 | 148 | 133 | 6 | 32538781 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 20. | 3.19e-05 | 517 | 133 | 10 | 11780052 | |
| Pubmed | 3.29e-05 | 157 | 133 | 6 | 30186101 | ||
| Pubmed | ZHX3 FAT4 CHD7 RYR1 ESF1 ARVCF DDHD1 ZNF516 PLCB1 NOL7 PRRC2B | 3.64e-05 | 638 | 133 | 11 | 31182584 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOC2L NUP98 SRCAP PGRMC1 HNRNPC SUGP2 UBR5 CEBPZ SAFB2 UHRF1 NOL7 HERC2 DDX41 SCIN | 4.01e-05 | 1024 | 133 | 14 | 24711643 |
| Pubmed | 4.28e-05 | 18 | 133 | 3 | 12684764 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 8647862 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 27802169 | ||
| Pubmed | Host syndecan-1 promotes listeriosis by inhibiting intravascular neutrophil extracellular traps. | 4.34e-05 | 3 | 133 | 2 | 32453780 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 10352150 | ||
| Pubmed | Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer. | 4.34e-05 | 3 | 133 | 2 | 34445387 | |
| Pubmed | NOC2L NUP98 ZC3H18 CHD7 TTF1 ESF1 SUGP2 UBR5 CEBPZ HERC2 PRRC2B | 4.48e-05 | 653 | 133 | 11 | 22586326 | |
| Pubmed | FAT4 CDC42BPA NUP98 FAM91A1 NCAPH ESF1 DENND6A DTWD2 SUGP2 UBR5 ARHGAP21 PRRC2B | 4.63e-05 | 777 | 133 | 12 | 35844135 | |
| Pubmed | 4.64e-05 | 167 | 133 | 6 | 25659891 | ||
| Pubmed | 4.69e-05 | 102 | 133 | 5 | 26584622 | ||
| Pubmed | 5.07e-05 | 19 | 133 | 3 | 15647280 | ||
| Pubmed | 5.15e-05 | 104 | 133 | 5 | 9205841 | ||
| Pubmed | CCDC22 VPS72 RANBP3 SRCAP NCAPH ESF1 SUGP2 CEBPZ TAF1 PRRC2B | 5.27e-05 | 549 | 133 | 10 | 38280479 | |
| Pubmed | 5.39e-05 | 251 | 133 | 7 | 29778605 | ||
| Pubmed | 5.39e-05 | 105 | 133 | 5 | 9628581 | ||
| Pubmed | 6.02e-05 | 347 | 133 | 8 | 17114649 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 FKBP15 RANBP3 NUP98 SRCAP NCAPH ESF1 SUGP2 SAFB2 PPP1R9B SCIN ARHGAP21 PRRC2B | 6.40e-05 | 934 | 133 | 13 | 33916271 |
| Pubmed | 6.91e-05 | 21 | 133 | 3 | 22467210 | ||
| Pubmed | 8.13e-05 | 268 | 133 | 7 | 33640491 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 7812048 | ||
| Pubmed | Heparin binding by the HIV-1 tat protein transduction domain. | 8.67e-05 | 4 | 133 | 2 | 11567105 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 18093920 | ||
| Pubmed | Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. | 8.67e-05 | 4 | 133 | 2 | 9111037 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 17368428 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 9276666 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 23965992 | ||
| Pubmed | Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. | 8.67e-05 | 4 | 133 | 2 | 10497173 | |
| Pubmed | HIV-tat protein is a heparin-binding angiogenic growth factor. | 8.67e-05 | 4 | 133 | 2 | 8570206 | |
| Pubmed | Cell communication using intrinsically disordered proteins: what can syndecans say? | 8.67e-05 | 4 | 133 | 2 | 24956062 | |
| Pubmed | Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. | 8.67e-05 | 4 | 133 | 2 | 11024024 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 12885232 | ||
| Pubmed | 9.15e-05 | 23 | 133 | 3 | 14966270 | ||
| Pubmed | 1.11e-04 | 282 | 133 | 7 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.14e-04 | 283 | 133 | 7 | 30585729 | |
| Pubmed | MAPK8IP1 SNPH CTTNBP2 CAMSAP3 HNRNPC SUGP2 ARVCF PTPRZ1 AJM1 RPTOR PRKAR2B PPP1R9B METAP2 ARHGAP21 CEP170B PRRC2B | 1.20e-04 | 1431 | 133 | 16 | 37142655 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 CTTNBP2 ATXN7L2 NUP98 ZC3H18 DTNBP1 ABRAXAS2 UBR5 PPP1R9B HERC2 CDC25B DDX41 PRRC2B | 1.33e-04 | 1005 | 133 | 13 | 19615732 |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 23341029 | ||
| Pubmed | HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex. | 1.44e-04 | 5 | 133 | 2 | 23612978 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 1765004 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 27721409 | ||
| Pubmed | Contribution of Syndecans to the Cellular Entry of SARS-CoV-2. | 1.44e-04 | 5 | 133 | 2 | 34069441 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 9342064 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 19805913 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 36056023 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 16157597 | ||
| Pubmed | ZHX3 FKBP15 NUP98 THUMPD1 ZC3H18 NCAPH ESF1 SUGP2 UBR5 SAFB2 UHRF1 TAF1 DDX41 | 1.45e-04 | 1014 | 133 | 13 | 32416067 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | SP3 ATN1 NOC2L OGFR JPH2 HNRNPC ZBTB7A ARVCF UHRF1 TAF1 MAPKBP1 PHF10 SDC4 | 1.55e-04 | 1021 | 133 | 13 | 26760575 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.57e-04 | 298 | 133 | 7 | 32353859 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FKBP15 NOC2L FAM91A1 DTNBP1 HNRNPC ABRAXAS2 STK10 UBR5 RPTOR CDC25B METAP2 ARHGAP21 TGS1 | 1.82e-04 | 1038 | 133 | 13 | 26673895 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPA CAMSAP3 TTF1 HNRNPC TTC19 STK10 ZBTB7A ZBTB46 IFRD1 SUGP2 RPTOR ANKRD11 SDC3 STYXL1 PPP1R9B CEP170B | 1.88e-04 | 1489 | 133 | 16 | 28611215 |
| Pubmed | ATN1 CAMSAP3 FAM91A1 ESF1 ARVCF DDHD1 CDC25B ARHGAP21 PRRC2B SORL1 | 2.09e-04 | 650 | 133 | 10 | 38777146 | |
| Pubmed | 2.16e-04 | 6 | 133 | 2 | 12112370 | ||
| Pubmed | 2.16e-04 | 6 | 133 | 2 | 22070227 | ||
| Pubmed | Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation. | 2.16e-04 | 6 | 133 | 2 | 23362280 | |
| Pubmed | The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. | 2.16e-04 | 6 | 133 | 2 | 18497260 | |
| Pubmed | 2.16e-04 | 6 | 133 | 2 | 11784020 | ||
| Pubmed | 2.16e-04 | 418 | 133 | 8 | 34709266 | ||
| Pubmed | 2.37e-04 | 225 | 133 | 6 | 12168954 | ||
| Interaction | DHX40 interactions | NOC2L ZC3H18 HNRNPC ESF1 UBR5 CEBPZ ANKRD11 ZBTB10 TAF1 DDX41 | 4.70e-06 | 249 | 129 | 10 | int:DHX40 |
| Interaction | HDAC1 interactions | DCAF1 ZHX3 SP3 CDC42BPA EID3 PPM1E CAMSAP3 NUP98 E4F1 NCAPH PGRMC1 HNRNPC ZBTB7A IFRD1 UBR5 ZNF516 UHRF1 PRKAR2B TAF1 ARHGAP21 BAHCC1 | 7.28e-06 | 1108 | 129 | 21 | int:HDAC1 |
| Interaction | PAX6 interactions | RANBP3 CHD7 SRCAP RFXAP HNRNPC ZNF516 DHPS ZBTB10 TAF1 PHF10 PRRC2B | 2.40e-05 | 366 | 129 | 11 | int:PAX6 |
| Interaction | PNMA2 interactions | CAMSAP3 HIC2 UBR5 PNMA8A SAFB2 HERC2 ARHGAP21 CEP170B PRRC2B | 3.49e-05 | 251 | 129 | 9 | int:PNMA2 |
| Interaction | SCML1 interactions | 3.77e-05 | 59 | 129 | 5 | int:SCML1 | |
| Interaction | FOXL1 interactions | 3.87e-05 | 196 | 129 | 8 | int:FOXL1 | |
| Interaction | FEV interactions | 4.97e-05 | 203 | 129 | 8 | int:FEV | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.51e-04 | 797 | 133 | 9 | chr19p13 | |
| Cytoband | 19p13.3 | 6.61e-04 | 237 | 133 | 5 | 19p13.3 | |
| Cytoband | 8q22 | 8.53e-04 | 15 | 133 | 2 | 8q22 | |
| Cytoband | 9q34.13 | 1.69e-03 | 21 | 133 | 2 | 9q34.13 | |
| Cytoband | 20q12 | 2.20e-03 | 24 | 133 | 2 | 20q12 | |
| Cytoband | 18q23 | 3.21e-03 | 29 | 133 | 2 | 18q23 | |
| Cytoband | 17q25.3 | 3.22e-03 | 101 | 133 | 3 | 17q25.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZHX3 SP3 ZBTB8B HIC2 E4F1 ZBTB7A ZBTB46 ZNF516 FIZ1 ZBTB10 ZNF367 ZNF697 | 1.15e-04 | 718 | 84 | 12 | 28 |
| GeneFamily | CD molecules|Syndecans | 1.27e-04 | 4 | 84 | 2 | 571 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.97e-04 | 181 | 84 | 6 | 694 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.01e-04 | 134 | 84 | 5 | 861 | |
| GeneFamily | INO80 complex |SRCAP complex | 7.52e-04 | 9 | 84 | 2 | 1329 | |
| GeneFamily | Potassium voltage-gated channels | 8.44e-04 | 40 | 84 | 3 | 274 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | DENND5B APC2 PPM1E CAMSAP3 POU3F1 CHD7 ESF1 IFRD1 RRAGD ARVCF UBR5 CEBPZ PTPRZ1 ZBTB10 UHRF1 CDC25B ARHGAP21 ZNF367 TGS1 | 8.37e-06 | 989 | 129 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-08 | 161 | 131 | 8 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-08 | 161 | 131 | 8 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.95e-07 | 178 | 131 | 7 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.36e-06 | 144 | 131 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.56e-06 | 162 | 131 | 6 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.18e-06 | 164 | 131 | 6 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.18e-06 | 164 | 131 | 6 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 165 | 131 | 6 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 165 | 131 | 6 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.84e-06 | 166 | 131 | 6 | de319c960b0cd90b294f677d1ea1b013a2ce2d53 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-05 | 175 | 131 | 6 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-05 | 175 | 131 | 6 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 182 | 131 | 6 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 185 | 131 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 189 | 131 | 6 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 189 | 131 | 6 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 196 | 131 | 6 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 200 | 131 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; HL60; HT_HG-U133A | 1.50e-06 | 190 | 130 | 9 | 1342_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-06 | 197 | 130 | 9 | 6105_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.02e-06 | 197 | 130 | 9 | 3304_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.11e-06 | 198 | 130 | 9 | 3680_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.11e-06 | 198 | 130 | 9 | 842_UP | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.20e-06 | 199 | 130 | 9 | 5498_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.61e-05 | 194 | 130 | 8 | 3747_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 5591_DN | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 3284_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 6611_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 5201_DN | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 4142_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 3865_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 7031_DN | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 4428_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 2713_DN | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; HL60; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 2706_DN | |
| Drug | Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 2.00e-05 | 200 | 130 | 8 | 6264_UP | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.00e-05 | 200 | 130 | 8 | 5264_DN | |
| Drug | mithramycin SK | 3.24e-05 | 2 | 130 | 2 | ctd:C520007 | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 8.01e-05 | 180 | 130 | 7 | 5306_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.12e-04 | 190 | 130 | 7 | 5218_DN | |
| Drug | 5707885; Down 200; 50uM; PC3; HT_HG-U133A | 1.16e-04 | 191 | 130 | 7 | 6390_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.20e-04 | 192 | 130 | 7 | 7427_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 4173_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.24e-04 | 193 | 130 | 7 | 864_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 1667_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 5602_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 4134_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 5450_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 5641_DN | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 5630_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 3245_UP | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 6913_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 3523_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 4019_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 2708_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 2962_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 4292_DN | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 4206_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 2236_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 7423_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 5288_UP | |
| Drug | Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 3547_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 4125_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 6646_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 5438_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 3530_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 2667_DN | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.36e-04 | 196 | 130 | 7 | 982_DN | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 6905_UP | |
| Drug | Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 6483_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 1658_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 4826_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 6014_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2887_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 3270_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 4137_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2269_DN | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; HL60; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 2196_UP | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 3301_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 3566_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 6999_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | 1.41e-04 | 197 | 130 | 7 | 449_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 3575_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 1215_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 3309_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 5807_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6046_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 1851_UP | |
| Drug | Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 1335_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 4675_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6263_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6259_DN | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6587_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 3509_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 1689_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 3018_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6270_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6292_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 1825_DN | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6889_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 3381_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 3608_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 3216_UP | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 5997_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2618_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 3410_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6079_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HG-U133A | 1.50e-04 | 199 | 130 | 7 | 1892_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2803_DN | |
| Drug | oxamic acid sodium salt; Down 200; 10000uM; MCF7; HG-U133A | 1.50e-04 | 199 | 130 | 7 | 439_DN | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6217_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2057_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6024_UP | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 6676_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 3549_UP | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | 1.54e-04 | 200 | 130 | 7 | 383_UP | |
| Drug | HHCA | 3.20e-04 | 5 | 130 | 2 | CID009576894 | |
| Drug | from Dendrobium nobile | 3.20e-04 | 5 | 130 | 2 | CID000355017 | |
| Disease | platelet component distribution width | CEP68 ADRB1 BRF1 ARVCF DDHD1 EPC1 DHPS ZBTB10 PLCB1 PPP1R9B ZNF367 TGS1 | 9.09e-05 | 755 | 125 | 12 | EFO_0007984 |
| Disease | Acute erythroleukemia - M6a subtype | 4.90e-04 | 8 | 125 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 4.90e-04 | 8 | 125 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 4.90e-04 | 8 | 125 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 4.90e-04 | 8 | 125 | 2 | C2930974 | |
| Disease | corpus callosum anterior volume measurement | 6.07e-04 | 39 | 125 | 3 | EFO_0010295 | |
| Disease | myeloid white cell count | FKBP15 CDC42BPA VPS72 CHD7 ZBTB7A ADRB1 ARVCF ZNF516 PLCB1 STYXL1 SORL1 TGS1 | 6.47e-04 | 937 | 125 | 12 | EFO_0007988 |
| Disease | albuminuria | 6.97e-04 | 94 | 125 | 4 | EFO_0004285 | |
| Disease | temporomandibular joint disorder | 7.84e-04 | 10 | 125 | 2 | EFO_0005279 | |
| Disease | corpus callosum volume measurement | 8.79e-04 | 100 | 125 | 4 | EFO_0010299 | |
| Disease | non-melanoma skin carcinoma | 9.54e-04 | 265 | 125 | 6 | EFO_0009260 | |
| Disease | Hypermetropia | 9.82e-04 | 103 | 125 | 4 | HP_0000540 | |
| Disease | multiple myeloma | 1.34e-03 | 112 | 125 | 4 | EFO_0001378 | |
| Disease | mean platelet volume | CHD7 SRCAP APOBR BRF1 DDHD1 EPC1 ANKRD11 ZBTB10 PLCB1 STYXL1 ZNF367 TGS1 | 1.34e-03 | 1020 | 125 | 12 | EFO_0004584 |
| Disease | Cardiovascular Abnormalities | 2.05e-03 | 16 | 125 | 2 | C0243050 | |
| Disease | Calcium channel blocker use measurement | 2.18e-03 | 213 | 125 | 5 | EFO_0009930 | |
| Disease | Global developmental delay | 2.51e-03 | 133 | 125 | 4 | C0557874 | |
| Disease | skin sensitivity to sun | 2.90e-03 | 19 | 125 | 2 | EFO_0004795 | |
| Disease | squamous cell carcinoma | 2.92e-03 | 67 | 125 | 3 | EFO_0000707 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 3.10e-03 | 335 | 125 | 6 | EFO_0009931 | |
| Disease | Stuttering | 3.26e-03 | 143 | 125 | 4 | HP_0025268 | |
| Disease | insomnia, total blood protein measurement | 3.68e-03 | 148 | 125 | 4 | EFO_0004536, EFO_0004698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGDADDSDADLGSAV | 481 | Q15361 | |
| AASDDDDDDVVGATP | 426 | P08588 | |
| LSGSSEAEEDNDPDG | 386 | Q9H2F5 | |
| SSFSDEDEDGPGLAA | 2321 | Q9P281 | |
| PQRAAGDSGEDSDDS | 361 | Q15018 | |
| DGAGPEDDTEASRAA | 2286 | Q6UB99 | |
| EDDTEASRAAAPAEG | 2291 | Q6UB99 | |
| LEDDTRSLAADDEGG | 261 | O00192 | |
| GHDADTEDDPSLADL | 146 | Q76N32 | |
| SGADDSFRIDPESGD | 1781 | Q6V0I7 | |
| DSLDGRSLNDDGSSD | 106 | P54259 | |
| GEAADASPEPSADED | 646 | C9J069 | |
| ELDPDSLSDASGSDG | 741 | Q9Y4F5 | |
| LGDASDTEAADGERG | 1131 | Q9Y4F5 | |
| DASEDADQPAGDSAI | 111 | O60826 | |
| EAKGSDDAPDADTAI | 366 | Q8N126 | |
| AVPAAAALGAEADDD | 36 | Q8NBA8 | |
| AALGAEADDDSADGL | 41 | Q8NBA8 | |
| SGEAEAEAEEADSGP | 646 | Q9P1Y5 | |
| DGSPAGAEDSLEEEA | 861 | Q9P1Y5 | |
| EADDADAAGRDSPSN | 771 | Q9P2D1 | |
| GDAAAELATDGDSDT | 111 | Q9HA90 | |
| ADLPAADGAELEESS | 36 | Q5T6C5 | |
| EDDSDDDDVLAPSGA | 536 | Q9H6Z4 | |
| TFPDADADEDSLAGE | 66 | Q8WXF3 | |
| DARAEAESPGGASES | 321 | Q86V59 | |
| LAAGSSLEEGGEFDD | 1011 | Q86T65 | |
| AGEDGDNDFSPSDEE | 1446 | Q9Y4B6 | |
| FDGLDDDEPSLANGA | 576 | P52948 | |
| ASTASLGEAAEGADE | 261 | Q9BR39 | |
| EGADEAAPFEADIDA | 271 | Q9BR39 | |
| GADDSAEEGDLLDDD | 256 | P07910 | |
| EALEDSDGRQDSPAG | 836 | O00339 | |
| GDLDPDDREEGAAST | 16 | P50579 | |
| APSEDSGKDRDSDEA | 641 | Q9Y216 | |
| AAFDDVSGTDEGRPD | 676 | Q96S38 | |
| LTGEPAADDSSDDSD | 4801 | O95714 | |
| LIDATGDTPGAEDDE | 96 | Q9UQF2 | |
| SDASDERGEPDLASG | 671 | Q658Y4 | |
| EDDDKSDSGPDLARG | 291 | Q9H501 | |
| GCSDDLSSGEADVDP | 11 | Q8N140 | |
| ASEADPGAEDADEAA | 461 | A0A0J9YX94 | |
| EDSSQGPDSAGLADD | 441 | Q9UJ96 | |
| GPDSAGLADDSADAL | 446 | Q9UJ96 | |
| AALGADPAARDSDAE | 346 | Q9HB15 | |
| VRGDQPAASGDSDDD | 46 | O00264 | |
| SLAPVSATAGEDDDD | 166 | Q4G0M1 | |
| HTDREATPDGGEDSD | 336 | Q96EV8 | |
| ASDDDADDADGALAA | 776 | O14511 | |
| ADDADGALAAESTPF | 781 | O14511 | |
| DEDDTDFLSPSGGAR | 6 | Q5T1M5 | |
| VGEHSDEDAPSSDDL | 241 | Q03052 | |
| FSLTPAEGDTEEDDG | 256 | P30305 | |
| DPAAAQEGEDEGASA | 51 | Q9UEU5 | |
| DDALDSEGRDSEGPA | 186 | Q9UIX4 | |
| DDDDDDRGSDGLSIH | 1426 | P23471 | |
| VPAGGSRSEAEDEDD | 16 | Q9UJV9 | |
| DSSEDVDKGSLDADP | 311 | C9JSJ3 | |
| GEEDSSNSEDGDPDA | 706 | Q9Y3T9 | |
| SNSEDGDPDAEAGLA | 711 | Q9Y3T9 | |
| SSGAAAEPLEEDEEG | 41 | Q9UMY1 | |
| LDSSPSGSVEDEDGD | 491 | Q86Y26 | |
| EEEEEGAATAAAAPG | 96 | Q8WY54 | |
| ELPALDSDGDSDDGE | 291 | Q8WUB8 | |
| EGGDLDDSDSSLEGL | 1086 | O95996 | |
| DDSDSSLEGLEEAGP | 1091 | O95996 | |
| AGSSPSLEQDDGDEE | 546 | O75460 | |
| DLSRAPEDAAGAAAE | 11 | Q8WZ74 | |
| EFDGSDSGARPDEAV | 311 | P49366 | |
| DPAAAQEGEDEGASA | 51 | A6NGK3 | |
| DADSGLEPDELAGEN | 31 | Q6ZUT9 | |
| ALVAAGGAPEDDEED | 31 | Q8IWF6 | |
| SDDLDESGEIDLDGL | 71 | Q12982 | |
| SSFAEDGPEVLDEEG | 61 | O00458 | |
| EGTAAEAGDAPLASD | 276 | Q96SL8 | |
| PALSSDSDKEGEDEG | 781 | O60336 | |
| EDGEEEEAAPADAGA | 86 | P31323 | |
| PASSSGEDDDEDRAC | 221 | Q8NEL9 | |
| DEETALGPEAAAADT | 696 | Q66K89 | |
| KLGLGTDEDDPTADD | 381 | Q58FG1 | |
| SGPGDEEDLAAATTE | 501 | P39059 | |
| LEGSGDDDSFPDDEL | 61 | O75056 | |
| DDFELSGSGDLDDLE | 56 | P31431 | |
| DPDSGTEEGVLDFSD | 41 | Q9NQL2 | |
| SEEGPAEAGASEDSE | 6 | P0C263 | |
| EPETDEDEGAGAAEA | 4256 | P21817 | |
| SEGSDDELGNLDDDE | 886 | Q03701 | |
| DELGNLDDDEVSLGS | 891 | Q03701 | |
| ASDDEAGDAGDLASV | 671 | Q9HC10 | |
| EGPELEAAAAAGDAS | 6 | Q9HB75 | |
| EAAAAAGDASEDSDA | 11 | Q9HB75 | |
| LLAAGGDDELTDSED | 451 | Q9UHC7 | |
| AGARDADAGDEDEES | 31 | Q9NZT2 | |
| SGGAEEEAEDLSAPS | 481 | Q96JB3 | |
| RPICGASSGDDDDSD | 236 | Q96S99 | |
| EEEAASGASSALEAG | 216 | Q96TC7 | |
| DDAEEADTEPVSGGS | 1326 | Q2M3C7 | |
| FSSGDDLGEDDEDAP | 2186 | Q92673 | |
| ADEDRGQGDSSEEAP | 231 | O60279 | |
| EAAAAAAEPGFDDEE | 91 | Q6ZMZ0 | |
| DTSGEPAAEDEGDTA | 131 | Q9BUR4 | |
| AAAAAAADEGPAREE | 31 | Q8IW70 | |
| GEGSDELSFDPDDVI | 441 | P14317 | |
| PDGGDDDDIIADISN | 231 | Q9Y6U3 | |
| EDAGSDEEGDNPFSA | 1726 | P21675 | |
| DPAAAQEGEDEGASA | 51 | Q13066 | |
| GGESAASLEDLEDEE | 101 | O00287 | |
| SAEDGADSGFAAADD | 236 | O15079 | |
| SHDSDTRDGPEEGAE | 356 | Q6ZRS2 | |
| ARDEEQSEADAGSGP | 556 | Q6ZRS2 | |
| DQGSDAPARDFDGED | 1676 | Q5VT25 | |
| DKGPEQTADDADDAA | 931 | Q8N122 | |
| DDGAPGDEAASEDSE | 651 | Q76KP1 | |
| GDEAASEDSEEAAGP | 656 | Q76KP1 | |
| AELPSDGEAEGTADL | 506 | Q0VD83 | |
| DGEAEGTADLEATPE | 511 | Q0VD83 | |
| DGSLGDDFDANDEPD | 366 | Q15003 | |
| EGSEDLDGHSDPEES | 311 | Q86VR2 | |
| ADRDATNDDGDLPSD | 121 | Q86WC6 | |
| DGAAAEDGADEAEAE | 81 | Q6DKK2 | |
| ADEAAEDSGEEGAPE | 586 | Q92618 | |
| LDLSDAEPDAGEATA | 36 | P49767 | |
| DDDDSDSDGDGKDLV | 91 | Q9Y6J8 | |
| DDEEEAAAAAGAPAA | 76 | Q02447 | |
| GRDEGEEEDAVDAAS | 321 | O94804 | |
| GEAAEDDLAGAPALS | 926 | Q8IX01 | |
| LDDLDADADDGWAGL | 361 | Q5JSZ5 | |
| DSAHPEEGDLDLASE | 261 | Q14151 | |
| SPGAGEADTESDDDD | 501 | Q9NQ66 | |
| ASGDGELDLSGIDDL | 441 | Q92994 | |
| GSDFEDSEDREGDPE | 21 | Q5TEC3 | |
| GEAAAETDSRPADED | 111 | Q96T88 | |
| ADSGADARGEEAEAA | 286 | P0DKB5 | |
| DLEASAGPAAGAAEE | 76 | Q96DT7 | |
| RPHASGTDGDESEED | 401 | Q96RS0 | |
| FDIDEGDEPSSDGEA | 61 | Q15906 | |
| AASGGEDEEEASSPD | 121 | Q7RTV3 | |
| GDEADDERSELISEG | 1616 | Q5T5U3 | |
| AAEDEGGEEDLASEL | 686 | Q9H4I2 | |
| SGSEGEDDDAEAALK | 86 | Q9NXG2 | |
| DDEGLAPEDALLADD | 551 | Q86UZ6 | |
| GAAAGDSDEESRADD | 331 | O95365 | |
| DLDDTDDGDDNAPLF | 2491 | O95071 | |
| DDILRDSGSDQDLDG | 26 | Q86VM9 | |
| ESGEENDPAGDDSDD | 466 | Q8NAP8 | |
| AGPSDEAGDDERELA | 171 | Q03721 | |
| ASGLEEDEASGLEEE | 421 | Q5T7N2 | |
| LGEDSAGSALEEDDE | 401 | Q96SB3 |